Dalfopristin
Back to searchMolecule Structure
Scientific Name
Dalfopristin
Description of the Drug
Dalfopristin is an antibiotic used with quinupristin to treat severe or life-threatening infections of vancomycin-resistant Enterococcus faecium (VREF), and skin infections caused by methicillin susceptible staphylococcus aureus or streptococcus pyogenes.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01764
http://www.drugbank.ca/drugs/DB01764
Brand Name(s)
Not Available
Company Owner(s)
King Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2363135 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL40993 |
DrugBank | DB01764 |
PubChem: Thomson Pharma | 14766240 |
PubChem | 6323289 |
Nikkaji | J492.987J |
PDBe | DOL |
EPA CompTox Dashboard | DTXSID10869549 |
Brenda | 227765 |
Guide to Pharmacology | 10797 |
rxnorm | DALFOPRISTIN |
ChEBI | 4309 |
ZINC | ZINC000003917540 |